Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 10Lung Neoplasms 10Breast Neoplasms 8Pancreatic Neoplasms 5Multiple Myeloma 5Brain Neoplasms 5Uterine Cervical Neoplasms 4Triple Negative Breast Neoplasms 4Papillomavirus Infections 4Ovarian Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Leukemia, Myeloid, Acute 3Hematopoietic and Lymphatic System Neoplasm 3Colorectal Neoplasms 3Urinary Bladder Neoplasms 2Stomach Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Inflammatory Breast Neoplasms 2Glioblastoma 2Fallopian Tube Neoplasms 2Soft Tissue Neoplasms 1Skin Neoplasms 1Sarcoma, Ewing 1Sarcoma 1Resectable Lung Non-Small Cell Carcinoma 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Patient Compliance 1Pancreatic Ductal Adenocarcinoma 1Obesity 1Neuroendocrine Tumors 1

Interventions

Specimen Handling 1Relaxation Therapy 1Physical Therapy Modalities 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Resectable Lung Non-Small Cell Carcinoma × Specimen Handling × Clear all
NCT07584239 2026-05-26

Prehabilitation Physical Therapy and Relaxation Intervention Program to Promote Resiliency and Operative Success Among Adults Receiving Lung Cancer Surgery, ROAR-LCS Trial

Ohio State University Comprehensive Cancer Center

Phase NA Recruiting
30 enrolled

Resectable Lung Non-Small Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡